Connect Conference & Show Floor Educational Sessions

View, browse and sort the list of Connect Conference sessions and show floor programming by pass type, track, and format. Please note, all Connect Conference delegates have access to CPhI Connect and InformEx Connect programming. Seating is first come, first serve, so please arrive early to sessions that you would like to attend. Sessions are subject to change.

To learn more about the Connect Conference program, click here.

All SessionsSpeakersMy Schedule
View Sessions As:
  
  • John DiLoretoExecutive DirectorBulk Pharmaceuticals Task Force

    John DiLoreto is the Executive Director of the Bulk Pharmaceuticals Task Force (BPTF), an industry trade organization representing manufacturers of active pharmaceutical ingredients, intermediates and excipients. Created as an affiliate organization of the Society of Chemical Manufacturers & Affiliates in response to industry demands, BPTF addresses regulatory and plant operations issues related to current Good Manufacturing Practices compliance.

    BPTF establishes sound working relationships with regulators, allied industries and the public and serves as a reliable source for the development and implementation of balanced regulations and industry guidance resources. BPTF undertakes this advocacy on behalf of its member companies to achieve drug product and drug substance supply chain safety for consumers. BPTF has been a key stakeholder in negotiations with FDA on the implementation of the Generic Drug User Fee Act (GDUFA).

    Prior to joining BPTF, Mr. DiLoreto founded NanoReg, a professional services firm specializing in nanotechnology applications and the laws and regulations related to the development and use of nanoscale materials throughout the nanotechnology value chain. Mr. DiLoreto has been instrumental in bringing together producers and users of nanoscale materials with government policy makers and non-governmental organizations to address environmental, health and safety concerns about the products of nanotechnology. As a national leader in the effort to engage industry in nanotechnology environmental, health and safety issues, Mr. DiLoreto has been recognized as a key player in the nanotechnology safety debate.

    Mr. DiLoreto combines his BS degree in Chemical Engineering with technical professional experience in the chemical and pharmaceutical industries to work with companies and trade associations to assist in a variety of industrial sectors throughout the nanotechnology and drug supply value chains.


    Presenting: